S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

SPRO Spero Therapeutics Inc

1.65

0.04 (2.48%)

May 03 2024 - Closed

Delayed by 15 minutes

Micro Cap Up Over +100% In Premarket

A Massachusetts-based biotech firm is grabbing the attention of traders across the board during Thursday’s premarket after it was announced that the company has entered into...

To read the full story on AllPennyStocks.com, click here.

Spero Therapeutics (NASDAQ:SPRO)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Spero Therapeutics Charts.

Spero Therapeutics (NASDAQ:SPRO)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Spero Therapeutics Charts.

Spero Therapeutics Inc News

Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024
Wednesday 6 March 2024 (2 months ago) • GlobeNewswire Inc.

Spero Therapeutics Announces Clearance of IND for SPR206 to Treat MDR Gram-negative Bacterial Infections
Wednesday 28 February 2024 (2 months ago) • GlobeNewswire Inc.

Spero Therapeutics to Present at Cowen’s 44th Annual Healthcare Conference
Monday 26 February 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 9 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 5 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 5 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 5 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 5 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 5 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Monday 5 February 2024 (3 months ago) • Edgar (US Regulatory)

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Wednesday 31 January 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 8 January 2024 (4 months ago) • Edgar (US Regulatory)

More Spero Therapeutics Inc News Articles

Code Green Apparel (PK)

Voip Pal Com (QB)

Kraig Biocraft Laborator... (QB)

Cann American (CE)

AMC Entertainment

Trump Media and Technology

1812 Brewing (PK)

Anavex Life Sciences

Rennova Health (PK)

Northwest Biotherapeutics (QB)

Digital Brand Media and ... (PK)

Impact Fusion (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions